Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 5/20 | 0.70 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.70 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | EGFR | P00533 | 2/20 | 0.44 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PNMT | P11086 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | SHBG | P04278 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8624471 | 0.90 | GABRA1 (0.57) | GABRA1GABRB2HSP90AA1CA1ACHE | |
| SCHEMBL23250736 | 0.85 | GABRA1 (0.61) | GABRA1GABRB2HSP90AA1EGFRPNMT | |
| SCHEMBL199730 | 0.83 | GABRA1 (1.00) | GABRA1GABRB2 | |
| SCHEMBL1552241 | 0.83 | HSP90AA1 (0.50) | GABRA1GABRB2HSP90AA1CA1ACHE | |
| SCHEMBL9751984 | 0.81 | HSP90AA1 (0.74) | GABRA1GABRB2HSP90AA1CA1ACHE | |
| SCHEMBL574233 | 0.79 | ALOX5 (0.53) | GABRA1GABRB2HSP90AA1EGFRERBB2 | |
| SCHEMBL28094939 | 0.79 | HSP90AA1 (0.47) | GABRA1GABRB2HSP90AA1CA1ACHE | |
| SCHEMBL5710254 | 0.79 | HSP90AA1 (0.55) | GABRA1GABRB2HSP90AA1CA1ACHE | |
| SCHEMBL24451093 | 0.79 | GABRA1 (0.52) | GABRA1GABRB2HSP90AA1 | |
| Alcohol SCHEMBL28268569 | 0.78 | GABRA1 (0.90) | GABRA1GABRB2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 334 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119875110-A | Polyphenylene ether, polyphenylene ether solution, resin film, prepreg, and metal-clad laminate | 旭化成株式会社 | 2025-04-25 | — | — | CN | claimed |
| CN-114736367-A | Green and safe polyarylether gas-liquid heterogeneous synthesis method | 常州中英科技股份有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-114716666-A | Polyarylether synthesis method based on gas-liquid heterogeneous phase method and continuous flow microchannel reactor | 常州中英科技股份有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-108641077-B | Synthetic method of polyphenyl ether | 广东省石油与精细化工研究院 | 2020-07-28 | — | — | CN | claimed |
| CN-108641077-A | A kind of synthetic method of polyphenylene oxide | 广东省石油与精细化工研究院 | 2018-10-12 | — | — | CN | claimed |
| US-20140135297-A1 | AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION | ISP INVESTMENTS INC. (US) | 2014-05-15 | — | — | US | claimed |
| WO-2012170841-A1 | AN AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION | ISP INVESTMENTS INC. (US) | 2012-12-13 | — | — | WO | claimed |
| EP-2313026-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | Castle Beach, L.L.C. (US) | 2011-04-27 | — | — | EP | claimed |
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | Castle Beach, LLC (US) | 2010-02-18 | — | — | US | claimed |
| WO-2010019680-A1 | ACTIVE DELIVERY SYSTEM FORMULATIONS | HOMOLA ANDREW M (US) | 2010-02-18 | — | — | WO | claimed |
| EP-1549731-B1 | CLEANING AND DISINFECTING COMPOSITION | RECKITT BENCKISER INC (US) | 2008-12-17 | — | — | EP | claimed |
| EP-0805672-B1 | METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH | HOMOLA ANDREW M (US) | 2004-08-25 | — | — | EP | claimed |
| US-5665333-A | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth | PROVSEAL LLC | 1997-09-09 | — | — | US | claimed |
| EP-3528776-B1 | REDUCED-ETHANOL MOUTH RINSE FORMULATIONS | KENVUE BRANDS LLC (US) | 2025-11-26 | — | — | EP | disclosed |
| US-12421349-B2 | Polyphenylene ether composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-09-23 | — | — | US | disclosed |
| EP-4282899-B1 | POLYPHENYLENE ETHER, PRODUCTION METHOD, THERMOSETTING COMPOSITION, PREPREG, AND LAMINATE THEREOF | ASAHI CHEMICAL IND (JP) | 2025-07-16 | — | — | EP | disclosed |
| US-4692555-A | Preparation of diphenolics | ETHYL CORPORATION (US) | 1987-09-08 | — | — | US | disclosed |
| US-4558119-A | WITH MANGANESE COMPOUND, N-ALKYLALKANOLAMINE, AND A BASIC COMPOUNDCATALYTIC MIXTURE | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1985-12-10 | — | — | US | disclosed |
| EP-0153074-A2 | Process for producing polyphenylene oxides | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1985-08-28 | — | — | EP | disclosed |
| EP-0132608-A1 | Process for the polymerization of a 2,6-disubstituted phenol | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1985-02-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100040565-A1 | ACTIVE DELIVERY SYSTEMS FORMULATIONS | LIPA, MMP7, CTSA | GABRA1 3441/4885GABRB2 3092/4885HSP90AA1 218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.